Abstract
The antimicrobial susceptibility of 229 strains of Staphylococcus aureus isolated from various skin infections was determined against 22 antimicrobial agents by the agar dilution method. The clinical isolates were most sensitive to vancomycin, teicoplanin, mupirocin and fusidic acid. No strains were resistant to vancomycin or teicoplanin. Three strains were highly resistant (MIC > or =100 mg/l) to mupirocin and eight strains to fusidic acid. The MIC(50) of all antimicrobials, except for gentamicin, were below 3.13 mg/l. The incidence of resistance to penicillin, cephalosporins and clindamycin ranged from 20 to 30%. The occurrence of gentamicin, erythromycin and roxithromycin resistance was high at 55.2, 39.6 and 39.1%, respectively. Methicillin resistance occurred in 21.0% of strains. The incidence of organisms with MIC > or =3.13 mg/l to oxacillin was 24.3%. These results were comparable to the average rate of MRSA in Japanese dermatological specimens.
References
Feb 1, 1991·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M Boyce
Feb 1, 1990·The Journal of Antimicrobial Chemotherapy·M Faber, V T Rosdahl
Jan 1, 1981·Chemotherapy·J E Riviere, G L Coppoc
Oct 2, 1981·JAMA : the Journal of the American Medical Association·P D Ellner, H C Neu
Apr 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M Shlaes, J H Shlaes
Feb 17, 1999·The British Journal of Dermatology·F Espersen
Aug 26, 2000·Journal of Dermatological Science·H AkiyamaJ Arata
Citations
Jan 23, 2013·Medical Molecular Morphology·Kenji FukutsujiTamotsu Harada
Jan 17, 2004·Journal of the American Academy of Dermatology·Philip R Cohen, Razelle Kurzrock
Aug 14, 2002·Journal of Applied Microbiology·K A Hoekstra, R J L Paulton
Sep 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin B Laupland, John M Conly
Jun 8, 2006·Journal of Clinical Microbiology·Norihisa NoguchiMasanori Sasatsu
Feb 3, 2004·Skin Pharmacology and Physiology·M SchallerH C Korting
Dec 7, 2013·International Journal of Biomedical Imaging·Fatima SbeityJean-Marc Girault
Feb 20, 2016·International Journal of Dermatology·Yoo Sang BaekHae Jun Song
Apr 14, 2007·Dermatologic Clinics·James Q Del Rosso, James J Leyden
Jul 10, 2004·Journal of the American Academy of Dermatology·Philip R Cohen, Marc E Grossman
Dec 2, 2005·International Journal of Antimicrobial Agents·Takashi KitaharaShun Higuchi
Jul 25, 2003·Expert Opinion on Pharmacotherapy·David R P Guay
Jul 1, 2009·Saudi Journal of Biological Sciences·M Al-Khulaifi ManalAli A Al Salamah
Feb 18, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S Subedi, K N Brahmadathan
Oct 22, 2014·Journal of the International Association of Providers of AIDS Care·Ruchi KotpalRavinder Kaur
Apr 15, 2005·Journal of Chemotherapy·L S StratchounskiE V Schetinin
May 8, 2003·Current Opinion in Infectious Diseases·E Anne Eady, Jonathan H Cove
Feb 11, 2016·Jundishapur Journal of Microbiology·Banafshe DormaneshLadan Afsharkhas
Jan 27, 2004·Pharmacotherapy·Kerry L Tedesco, Michael J Rybak
May 3, 2021·Antimicrobial Resistance and Infection Control·Bahareh HajikhaniMasoud Dadashi